Latest News and Press Releases

NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics has joined a new collaborative announced in response to the White House Cancer Moonshot, the Blood Profiling Atlas. The Atlas is a...

NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announced that it will present exhibit posters at the San Antonio Breast Cancer Symposium (SABCS), taking place December...

NEW YORK, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., will be presenting at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York as well as the Evercore ISI...

NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a poster presentation at the...

NEW YORK, July 28, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., a company developing and commercializing protein-based diagnostic, prognostic and monitoring tests for cancers affecting women,...

NEW YORK, July 07, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a private company developing and commercializing protein-based diagnostic, prognostic and monitoring tests for cancers affecting...

NEW YORK, June 02, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women,...

New York, NY, May 24, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., today announces that David Reese, Ph.D., President and Chief Executive Officer, will deliver a corporate overview at...

New York, April 06, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics Inc., a company developing and commercializing molecular diagnostic, prognostic and monitoring tests for cancers affecting women,...

New York, March 21, 2016 (GLOBE NEWSWIRE) -- NEW YORK, NY – March 21, 2016 - Provista Diagnostics, Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and...